ArticleEye and vision (London, England)2026
Effects of orthokeratology with different back optic zone diameters on corneal biomechanics and myopia control: a 1-year randomized, double-blind, self-controlled study.
Article in Eye and vision (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundTo assess the long-term effects of orthokeratology (ortho-k) lenses with varying back optic zone diameters (BOZDs) on corneal biomechanical properties and explore their relationship with myopia control.
methodsThis 1-year prospective, randomized, double-blind, self-controlled study enrolled 36 myopic children aged 9-12 years. Thirty subjects (60 eyes) completed the 1-year follow-up period. The subjects were randomly fitted with a 5-mm BOZD (5BOZD) lens in one eye and a 6-mm BOZD (6BOZD) lens in the fellow eye. Corneal biomechanics were measured using Corvis ST at baseline and at 1 day, 7 days, 1 month, 6 months, and 12 months after ortho-k wear. Axial length (AL) was measured at baseline, 6 months, and 12 months after ortho-k wear, and AL elongation (ΔAL) was calculated relative to baseline. Statistical analyses were performed to compare intergroup differences and examine the correlations between ΔAL and changes in biomechanical parameters.
resultsΔAL was significantly smaller in the 5BOZD groups compared to the 6BOZD groups at both 6 and 12 months (P < 0.05). The stiffness parameter at first applanation (SP-A1) significantly increased at 6 months in both groups (P < 0.05). At 12 months, the first applanation time (A1 time) and integrated radius significantly increased, while the first applanation velocity (A1 velocity) and stress-strain index (SSI) significantly decreased in both groups (P < 0.05). In the 6BOZD group, ΔAL showed a significant positive correlation with ΔA1 time at 6 and 12 months (r
conclusionsLong-term ortho-k therapy increased SP-A1, A1 time, integrated radius, and decreased A1 velocity, reflecting enhanced corneal resistance and elasticity. Compared to the 5BOZD lens, the traditional 6BOZD lens demonstrated relatively greater corneal elasticity, possibly reducing myopia control efficacy. A smaller BOZD may offset these corneal biomechanical changes and improve the management of myopia. Trial registration Chinese Clinical Trial Registry (ChiCTR2200061048).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.